Wave Life Sciences (WVE) Return on Sales Growth (3y) (2018 - 2026)

Wave Life Sciences (WVE) Return on Sales Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -
4 BeOne Medicines 469.79 Bn 465.00 Bn 1.35 Bn 1.00
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn 0.00
7 Belite Bio 62.62 Bn 62.62 Bn - -
8 Argenx Se 56.18 Bn 50.99 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Wave Life Sciences 1.19 Bn 643.41 Mn - 1.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00
Jun 30, 2025 104.00
Mar 31, 2025 16.00
Jun 30, 2024 12.00
Mar 31, 2024 7.00
Dec 31, 2023 2.00
Sep 30, 2023 10.00
Jun 30, 2023 12.00
Mar 31, 2023 9.00
Dec 31, 2022 -12.00
Sep 30, 2022 -120.00
Jun 30, 2022 -105.00
Mar 31, 2022 -7.00
Dec 31, 2021 -9.00
Sep 30, 2021 8.00
Jun 30, 2021 -7.00
Mar 31, 2021 16.00
Dec 31, 2020 24.00
Sep 30, 2020 10.00
Jun 30, 2020 9.00